![](/img/cover-not-exists.png)
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
Nitz, Ulrike, Gluz, Oleg, Christgen, Matthias, Kates, Ronald E., Clemens, Michael, Malter, Wolfram, Nuding, Benno, Aktas, Bahriye, Kuemmel, Sherko, Reimer, Toralf, Stefek, Andrea, Lorenz-Salehi, FatemLanguage:
english
Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-017-4358-6
Date:
June, 2017
File:
PDF, 1.12 MB
english, 2017